Filizola Lab

Icahn School of Medicine at Mount Sinai

PHARMACOLOGY

New York · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2025

Leveraging Integrative Modeling and AI-Based Tools to Develop Safer Opioids

PROJECT SUMMARY The misuse of opioid painkillers targeting the -opioid receptor (MOR) continues to result in record numbers of overdose deaths, underscoring the pressing need to identify safer analgesics, as well as effective therapies for opioid use disorder (OUD). Although efficacy with (e.g., preferable drugs that can sufficiently engage pain pathways to provide therapeutic relief while leading to lower side effects through reduced engagement of their mediating circuits. Understanding not free from liabilities, several MOR small-molecules that exhibit low- agonism for relevant G protein subtypes (e.g., buprenorphine and oliceridine) are powerful analgesics i mproved safety profiles…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Icahn School of Medicine at Mount Sinai